Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic Component

SIMPLE SUMMARY: Relapse as the most common reason for treatment failure after allogeneic hematopoietic stem-cell transplantation (allo-SCT) in myeloid neoplasms usually occurs during the first year post-transplant, but several patients experience late relapse. This retrospective study aimed to chara...

Descripción completa

Detalles Bibliográficos
Autores principales: Platte, Victoria, Bergmann, Anika, Hildebrandt, Barbara, Wieczorek, Dagmar, Schuler, Esther, Germing, Ulrich, Kaivers, Jennifer, Haas, Rainer, Kobbe, Guido, Schroeder, Thomas, Rautenberg, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776604/
https://www.ncbi.nlm.nih.gov/pubmed/36551729
http://dx.doi.org/10.3390/cancers14246244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776604/
https://www.ncbi.nlm.nih.gov/pubmed/36551729
http://dx.doi.org/10.3390/cancers14246244

Ejemplares similares